Omalizumab rapidly decreases nasal allergic response and FcεRI on basophilsHenry C. Lin, Thomas B. Casale, Barbara A. Foster et al.|Journal of Allergy and Clinical Immunology|2004Cited by 267
The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptomsJeffrey R. Stokes, Thomas B. Casale, F.A. Romero et al.|Journal of Allergy and Clinical Immunology|2011Cited by 59
Safety of the intranasal toll-like receptor 4 agonist CRX-675 in allergic rhinitisThomas B. Casale, F.A. Romero, Jean Kessler|Annals of Allergy Asthma & Immunology|2006Cited by 38
Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitisThomas B. Casale, Egilius L.H. Spierings, F.A. Romero|Journal of Allergy and Clinical Immunology|2007Cited by 33